Immuneering Corp (IMRX) — 10-Q Filings
All 10-Q filings from Immuneering Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Immuneering's Cash Soars to $227M Amid Widening Losses
— Nov 12, 2025 Risk: high
Immuneering Corp (IMRX) reported a net loss of $14,964,875 for the three months ended September 30, 2025, an increase from $14,597,366 for the same period in 20 -
Immuneering's Cash Dwindles Amid Widening Losses, Going Concern Doubts
— Aug 13, 2025 Risk: high
Immuneering Corp. reported a net loss of $14,433,881 for the three months ended June 30, 2025, an increase from a net loss of $14,079,927 for the same period in -
Immuneering Corp Files Q1 2025 10-Q
— May 5, 2025 Risk: low
Immuneering Corp filed its 10-Q for the period ending March 31, 2025. The company, located at 245 Main Street, Cambridge, MA, reported on its financial status. -
Immuneering Corp Files Q3 2024 10-Q
— Nov 13, 2024 Risk: medium
Immuneering Corp filed its Q3 2024 10-Q report on November 13, 2024, detailing its financial performance for the period ending September 30, 2024. The company, -
Immuneering Corp Files Q2 2024 10-Q
— Aug 6, 2024 Risk: medium
Immuneering Corp filed a 10-Q for the period ending June 30, 2024. The company, located at 245 Main Street, Cambridge, MA, reported financial data for its fisca -
Immuneering Corp Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: low
Immuneering Corp (IMRX) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Immuneering Corp filed a 10-Q report for the period ending March 31, 2024.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX